Kingchem (Liaoning) Life Science Co., Ltd. (SHE:301509)
China · Delayed Price · Currency is CNY 25.81
-0.51 (-1.94%)
At close: Nov 13, 2026
SHE:301509 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 3,109 | 4,069 | 3,117 | 5,432 | - | - | |
Market Cap Growth | -32.87% | 30.53% | -42.62% | - | - | - |
Enterprise Value | 2,192 | 3,486 | 2,420 | 3,981 | - | - |
Last Close Price | 25.81 | 32.76 | 24.84 | 42.68 | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 69.43 | 38.82 | 80.74 | 31.30 | - | - |
PS Ratio | 5.05 | 6.36 | 6.27 | 7.08 | - | - |
PB Ratio | 1.46 | 1.84 | 1.45 | 2.50 | - | - |
P/TBV Ratio | 1.49 | 1.88 | 1.48 | 2.56 | - | - |
P/FCF Ratio | - | 31.70 | 30.92 | 66.04 | - | - |
P/OCF Ratio | 41.54 | 23.91 | 20.12 | 35.01 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.56 | 5.45 | 4.87 | 5.19 | - | - |
EV/EBITDA Ratio | 26.30 | 22.84 | 33.14 | 15.50 | - | - |
EV/EBIT Ratio | 86.03 | 37.64 | 318.77 | 20.84 | - | - |
EV/FCF Ratio | - | 27.16 | 24.01 | 48.39 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.10 | 0.11 |
Debt / EBITDA Ratio | 0.04 | 0.02 | 0.06 | 0.04 | 0.40 | 0.55 |
Debt / FCF Ratio | - | 0.03 | 0.05 | 0.14 | 0.77 | - |
Net Debt / Equity Ratio | -0.43 | -0.59 | -0.55 | -0.25 | -0.28 | -0.20 |
Net Debt / EBITDA Ratio | -11.25 | -8.47 | -16.15 | -2.12 | -1.13 | -1.02 |
Net Debt / FCF Ratio | 50.77 | -10.08 | -11.70 | -6.64 | -2.16 | 1.40 |
Asset Turnover | 0.27 | 0.28 | 0.22 | 0.44 | 0.68 | 0.66 |
Inventory Turnover | 2.69 | 2.26 | 1.66 | 1.88 | 2.01 | 2.18 |
Quick Ratio | 8.23 | 15.53 | 14.02 | 5.98 | 1.90 | 2.32 |
Current Ratio | 12.98 | 17.27 | 16.25 | 15.37 | 2.85 | 3.66 |
Return on Equity (ROE) | 2.08% | 4.81% | 1.79% | 11.38% | 20.40% | 13.86% |
Return on Assets (ROA) | 0.69% | 2.53% | 0.21% | 6.78% | 9.93% | 6.90% |
Return on Invested Capital (ROIC) | 2.26% | 8.53% | 0.58% | 14.45% | 23.30% | 17.59% |
Return on Capital Employed (ROCE) | 1.20% | 4.20% | 0.30% | 8.70% | 17.70% | 12.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.44% | 2.58% | 1.24% | 3.19% | - | - |
FCF Yield | -0.58% | 3.16% | 3.23% | 1.51% | - | - |
Dividend Yield | 3.49% | 2.66% | 1.55% | 1.27% | - | - |
Payout Ratio | 240.55% | 46.15% | 179.10% | - | 2.55% | 58.51% |
Buyback Yield / Dilution | 0.09% | 0.15% | -20.26% | -10.97% | -0.77% | -28.18% |
Total Shareholder Return | 3.58% | 2.82% | -18.71% | -9.70% | -0.77% | -28.18% |